EICHOR
● Recruiting
Fecal Microbiota Transplantation in Crohn's Disease as Relay After Anti-TNF Withdrawal
Condition: Crohn Disease · Sponsor: Assistance Publique - Hôpitaux de Paris
About this study
Crohn's disease (CD) is a chronic inflammatory bowel disease. CD pathogenesis remains poorly understood but involves an inappropriate immune response toward an unbalanced gut microbiota in predisposed hosts. The purpose of this study is to evaluate de clinical efficacy of the fecal microbiota transplantation (FMT) as a maintenance treatment following anti-TNF agent withdrawal in CD's patient.
This description comes directly from the study's public registry record.
Talk to the study team
Harry SOKOL, PU-PH · 01 49 28 31 62 · harry.sokol@aphp.fr
Laurent BEAUGERIE, PU-PH · laurent.beaugerie@aphp.fr · laurent.beaugerie@aphp.fr
Always discuss trial participation with your own doctor first.
Locations (1)
| Gastroenterology Department of Saint Antoine Hospital | Paris, France | Recruiting |
Follow this study
Save your interest here for when the public record changes — results posted, or the study's status changes. Email alerts for this study aren't switched on yet.
We keep this only about this public record, and never email you without alerts being switched on. Want it removed at any time? Email hello@eichor.com. Never medical advice. By subscribing you agree to our Terms of Use and Privacy Policy.
This page is independently generated by Eichor from the public ClinicalTrials.gov record and re-synced daily. It is not the sponsor's official website unless claimed. Nothing here is medical advice; eligibility is always determined by the study team — talk to your own doctor first.
Source record: clinicaltrials.gov/study/NCT04997733